Imax price target raised to $26 from $24 at Roth MKM

Roth MKM analyst Eric Handler raised the firm’s price target on Imax to $26 from $24 and keeps a Buy rating on the shares after its Q1 earnings beat. The company’s 2023 is off to a strong start and box office momentum is carrying over nicely into Q2, the analyst tells investors in a research note.